NASDAQ: NUVL
Nuvalent Inc Stock Ownership - Who owns Nuvalent?

Insider buying vs selling

Have Nuvalent Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Henry E. PelishChief Scientific Officer2025-09-10877$27.85
$24.42kBuy
Henry E. PelishChief Scientific Officer2025-09-103,725$78.83
$293.64kSell
Henry E. PelishChief Scientific Officer2025-09-102,117$29.33
$62.09kBuy
Henry E. PelishChief Scientific Officer2025-09-10731$18.93
$13.84kBuy
Henry E. PelishChief Scientific Officer2025-08-292,007$0.87
$1.75kBuy
Henry E. PelishChief Scientific Officer2025-08-293,000$1.08
$3.24kBuy
Darlene NociChief Development Officer2025-08-25109$75.63
$8.24kSell
Darlene NociChief Development Officer2025-08-254,000$27.85
$111.40kBuy
Darlene NociChief Development Officer2025-08-251,348$73.96
$99.70kSell
Darlene NociChief Development Officer2025-08-252,543$74.93
$190.55kSell

1 of 19

NUVL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NUVL insiders and whales buy or sell their stock.

NUVL Shareholders

What type of owners hold Nuvalent Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James E. Flynn25.86%18,646,022$1.50BInsider
Deerfield Management Company LP24.95%17,991,024$1.45BInstitution
Fmr LLC13.83%9,968,846$802.19MInstitution
Paradigm Biocapital Advisors LP7.31%5,269,433$424.03MInstitution
Vanguard Group Inc6.27%4,524,124$364.06MInstitution
Blackrock Inc5.61%4,046,256$325.60MInstitution
Price T Rowe Associates Inc2.49%1,795,373$144.47MInstitution
Janus Henderson Group PLC2.47%1,782,581$143.44MInstitution
Matthew Shair2.28%1,646,366$132.48MInsider
Wellington Management Group LLP2.19%1,576,374$126.85MInstitution

1 of 3

NUVL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NUVL75.08%24.92%Net SellingNet Buying
AXSM70.64%29.36%Net SellingNet Selling
CYTK90.09%9.91%Net SellingNet Selling
LEGN22.93%0.00%
NNNN0.02%0.00%

Nuvalent Stock Ownership FAQ

Who owns Nuvalent?

Nuvalent (NASDAQ: NUVL) is owned by 99.70% institutional shareholders, 33.10% Nuvalent insiders, and 0.00% retail investors. James E. Flynn is the largest individual Nuvalent shareholder, owning 18.65M shares representing 25.86% of the company. James E. Flynn's Nuvalent shares are currently valued at $1.50B.

If you're new to stock investing, here's how to buy Nuvalent stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.